Track topics on Twitter Track topics that are important to you
Poxel is a new RIPCO that aims to advance promising assets for cardio-metabolic diseases from Research to Phase 2 Clinical Proof of Concept, before out licensing projects to pharmaceutical companies. Poxel will further develop its portfolio by considering all opportunities corresponding to its core domain of competencies.
Japan's Sumitomo Dainippon Pharma announced a $300 million deal to develop Poxel's novel type 2 diabetes treatment in Japan, China and eleven other SE Asian countries. Poxel, a French biopharma, has c...
Wednesday, September 6th 2017 at 6:00am UTC Lyon, FRANCE–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of inno...
Monday, August 28th 2017 at 6:00am UTC Additional data from metabolic syndrome model support protective effects of Imeglimin on diabetic cardiomyopathy, a significant cardiovascular complication in di...
POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes,...
Sumitomo Dainippon Pharma has gained rights to Poxel's type 2 diabetes drug PXL008, or imeglimin, in China, Japan, Taiwan, So -More-
Poxel SA licensed Sumitomo Dainippon Pharma Co. Ltd. rights to develop and commercialize its Phase II Type II diabetes candidate imeglimin in Japan, China, South Korea, Taiwan, Indonesia, Vietnam, Tha...
MERCK SANTÉ SAS / MERCK ANNOUNCES SALE OF POXEL EQUITY STAKE . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Press .....
Poxel is a new RIPCO that aims to advance promising assets for cardio-metabolic diseases from Research to Phase 2 Clinical Proof of Concept, before out licensing projects to pharmaceutical compani...
We have published hundreds of Poxel SAS news stories on BioPortfolio along with dozens of Poxel SAS Clinical Trials and PubMed Articles about Poxel SAS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Poxel SAS Companies in our database. You can also find out about relevant Poxel SAS Drugs and Medications on this site too.
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...